Free Trial
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel
NASDAQ:ABP

Abpro Q3 2025 Earnings Results & Report

Abpro logo
$0.52 0.00 (0.00%)
As of 10/14/2026

Abpro beat analyst earnings expectations in its Q3 2025 results, released November 14, 2025. The company reported EPS of -$0.63 versus the -$1.20 consensus estimate.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

Abpro EPS Results

Actual EPS
-$0.63
Consensus EPS
-$1.20
Beat/Miss
Beat by +$0.57
One Year Ago EPS
N/A

Abpro Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Abpro Q3 2025 Earnings FAQ

Abpro (NASDAQ:ABP) reported earnings of -$0.63 per share for Q3 2025, beating the consensus estimate of -$1.20. The report was announced on Friday, November 14, 2025.

Abpro Earnings Headlines

Abpro Holdings Faces Nasdaq Delisting, Moves to OTC
June 23, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2334035/abpro-holdings-faces-nasdaq-delisting-moves-to-otc/
Abpro Holdings Directors Resign, Board Seeks Replacements
June 22, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/31555/abpro-holdings-directors-resign-board-seeks-replacements/
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
October 15 at 1:00 AM  |  Chaikin Analytics (Ad)
ABPO Abpro Holdings, Inc.
May 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/ABPO
Abpro Bio Co. Ltd.
April 16, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/195990/financials?countrycode=kr
Abpro Holdings Equity Warrant Exp 12th Nov 2029
April 14, 2026  |  cnbc.comhttps://www.cnbc.com/quotes/ABPWW
See More Abpro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abpro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abpro and other key companies, straight to your email.

About Abpro

Abpro (NASDAQ:ABP) is a clinical-stage biotechnology company focused on developing antibody-based therapeutics for cancer and other serious diseases. The company uses proprietary antibody discovery and engineering technologies to develop treatments designed to target disease-related proteins and stimulate targeted immune responses.

Abpro’s research programs include bispecific antibodies, which are engineered to bind to two different targets, including approaches designed to direct immune cells toward cancer cells. Its pipeline has included candidates aimed at solid tumors and other oncology applications, although the development status and composition of individual programs may change as clinical and regulatory work progresses.

The company has historically operated as an antibody therapeutics developer serving the global biopharmaceutical market. Abpro became publicly traded on the Nasdaq under the symbol ABP following its business combination and listing in 2024. Publicly available information about its current leadership and broader commercial operations is limited.

View Abpro Profile
Earnings Tools